Search
Skip to Search Results
Filter
Author / Creator / Contributor
- 2Young, T. Kue
- 1Adams, Scott C
- 1Alberta Centre for Active Living
- 1Ambrose, Divakar J.
- 1Anderson, T.
- 1Archer, S.
Year
Collections
- 14Graduate and Postdoctoral Studies (GPS), Faculty of
- 14Graduate and Postdoctoral Studies (GPS), Faculty of /Theses and Dissertations
- 2Nursing, Faculty of
- 2School of Public Health
- 2School of Public Health/Journal Articles (Public Health)
- 1Alberta Centre for Active Living
Languages
Item type
Departments
- 2Department of Agricultural, Food, and Nutritional Science
- 2Department of Public Health Sciences
- 2Physical Education and Recreation
- 2School of Public Health Sciences
- 1Department of Medicine
- 1Department of Physiology
Supervisors
- 2Proctor, Spencer (Agricultural, Food and Nutritional Science)
- 1Baker, Glen (Psychiatry)
- 1Berry, Tanya (Physical Education and Recreation)
- 1Colman, Ian (Epidemiology and Community Medicine)
- 1Courneya, Kerry (Physical Education and Recreation)
- 1Davidge, Sandra (Obstetrics/Gynecology and Physiology)
-
Spring 2014
Modifiable cardiovascular disease (CVD) risk factors, such as adiposity, are already associated with atherosclerotic progression in childhood. Less is known about whether physical activity (PA) is associated with progression of atherosclerosis in non-clinical samples of children. This...
-
The role of ezetimibe and simvastatin in modulating intestinal cholesterol transport, chylomicron profile and chylomicron-remnant uptake by the arterial wall in a rodent model of the metabolic syndrome
DownloadFall 2010
Intestinally derived chylomicron remnants (CM-r) may contribute to atherogenic dyslipidemia during the Metabolic Syndrome (Mets). However, the combined effects of ezetimibe (EZ) and simvastatin (SV) on post-prandial (PP) dyslipidemia during MetS remains unclear, nor is it known whether the...
21 - 22 of 22